Testing effectiveness (Phase 2)Study completedNCT02658019What this trial is testingPembrolizumab (Keytruda) in Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Lynn Feun, MD 29
Testing effectiveness (Phase 2)Study completedNCT03044587What this trial is testingNal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract CancerWho this might be right forAdenocarcinoma MetastaticBiliary Tract CancerAdenocarcinoma of the Biliary Tract+4 more AIO-Studien-gGmbH 93
Testing effectiveness (Phase 2)UnknownNCT02967887What this trial is testingEvaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCCWho this might be right forHepatocellular Carcinoma Non-Resectable CbsBioscience 96
Early research (Phase 1)Study completedNCT01183663What this trial is testingLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)Who this might be right forAdvanced Cancers M.D. Anderson Cancer Center 180
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT01567930What this trial is testingTemsirolimus as Second-line Therapy in HCCWho this might be right forUnresectable or Metastatic Hepatocellular Carcinoma University of Tennessee Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00941967What this trial is testingSorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver CancerWho this might be right forLiver Cancer Institut du Cancer de Montpellier - Val d'Aurelle 78
Not applicableStudy completedNCT00607828What this trial is testingStereotactic Radiation Therapy in Treating Patients With Advanced Liver CancerWho this might be right forLiver Cancer University of Nebraska 7
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Study completedNCT00005629What this trial is testingVaccine Therapy in Treating Patients With Liver CancerWho this might be right forLiver Cancer Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT03419897What this trial is testingStudy of BGB-A317 in Participants With Previously Treated Unresectable HCCWho this might be right forHepatocellular Carcinoma (HCC) BeiGene 249
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511504What this trial is testingY-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular CarcinomaWho this might be right forLocally Advanced Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8+1 more OHSU Knight Cancer Institute 40
Not applicableNot Yet RecruitingNCT07535840What this trial is testingA Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular CarcinomaWho this might be right forHCC - Hepatocellular CarcinomaTP53 Gene MutationUnresectable+1 more Tongji Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06737913What this trial is testingHAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular CarcinomaWho this might be right forAdvanced Hepatocellular Carcinoma (HCC) Sun Yat-sen University 76
Testing effectiveness (Phase 2)Study completedNCT00083226What this trial is testingDoxorubicin and Bortezomib in Treating Patients With Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)UnknownNCT00276705What this trial is testingCombination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver CancerWho this might be right forLiver Cancer Children's Cancer and Leukaemia Group 47
Testing effectiveness (Phase 2)UnknownNCT00003296What this trial is testingLiposomal Doxorubicin in Treating Patients With Liver or Bile Duct CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Brown University 26
Early research (Phase 1)Study completedNCT00028496What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT04599790What this trial is testingTACE Combined With Lenvatinib and Sintilimab for Advanced HCCWho this might be right forHepatocellular Carcinoma Non-resectable Second Affiliated Hospital of Guangzhou Medical University 30